Clinical Trial Update: Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating vapreotide to reduce perioperative and postoperative complications in patients undergoing elective pancreatic resection for pancreati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Vapreotide (vapreotide)

Snippet

Sponsor: Mayo Clinic | Conditions: Pancreatic Cancer, Perioperative/Postoperative Complications | Phase 3 | Status: TERMINATED